(Q39474102)

English

Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients

scientific article published on February 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

methicillin-resistant Staphylococcus aureus

0 references

cystic fibrosis

0 references

secondary metabolite

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

Marcello Nicoletti

5

object named as

Marcello Nicoletti

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Giovanni Di Bonaventura

8

object named as

Giovanni Di Bonaventura

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

Arianna Pompilio

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Stefano Pomponio

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Valentina Di Vincenzo

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Valentina Crocetta

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Marisa Piovano

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Juan A Garbarino

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Future Microbiology

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

281-292

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Challenging and emerging pathogens in cystic fibrosis

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Adaptation of Staphylococcus aureus to the cystic fibrosis lung.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Phytochemicals for bacterial resistance--strengths, weaknesses and opportunities

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Challenges of antibacterial discovery

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

New strategies for combating multidrug-resistant bacteria

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

In vitro interaction of usnic acid in combination with antimicrobial agents against methicillin-resistant Staphylococcus aureus clinical isolates determined by FICI and ΔE model methods

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

In vitro antimicrobial activity of pannarin alone and in combination with antibiotics against methicillin-resistant Staphylococcus aureus clinical isolates

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Antimycobacterial activity of lichen substances

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Biologically active components of a Papua New Guinea analgesic and anti-inflammatory lichen preparation

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

In vitro and in vivo immunomodulating effects of traditionally prepared extract and purified compounds from Cetraria islandica.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Biofilm formation by and accessory gene regulator typing of methicillin-resistant Staphylococcus aureus strains recovered from patients with nosocomial infections

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Hepatotoxic slimming aids and other herbal hepatotoxins.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Hepatotoxic effect of (+)usnic acid from Usnea siamensis Wainio in rats, isolated rat hepatocytes and isolated rat liver mitochondria

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.142

21 January 2018

The antimicrobial activity of extracts of the lichen Cladonia foliacea and its (-)-usnic acid, atranorin, and fumarprotocetraric acid constituents.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1515/ZNC-2004-3-423

Identifiers

10.2217/FMB.12.142

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39474102&oldid=2129246637"